Key facts
- This page summarizes TardiMed Sciences LLC's Form 4 filing for PaxMedica, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Sep 2022, 16:07.
TardiMed Sciences LLC - 30 Aug 2022 Form 4 Insider Report for PaxMedica, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 30 Aug 2022
- Net transaction value
- +$498,750
- SEC form
- 4
- Accepted by SEC
- 01 Sep 2022, 16:07:20 UTC
- Prior SEC filing
- 12 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
TardiMed Sciences LLC filed Form 4 for PaxMedica, Inc. on 01 Sep 2022.
Change
- Previous filing in this sequence was filed on 12 Aug 2022.
- Current net transaction value: +$498,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PXMD
transaction
Common Stock
Purchase
- Transaction value
- $498,750
- Shares
- +95,000
- Change %
- +1.3%
- Price
- $5.25*
- Shares after
- 7,336,745
- Date
- 30 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares were purchased from the underwriters by the reporting person in the issuer's initial public offering, which closed on August 30, 2022.